Your patients suffer from sleep apnea,
and their diagnosis lies in your hands
Meet the Biologix Sleep Test®
The Biologix Sleep Test® is a type IV polysomnography used for the diagnosis of both snoring and sleep apnea. It allows accredited health practitioners to offer their patients a simplified solution using only a smartphone and a compact, wireless sensor.
The Oxistar® Sensor
The healthcare practitioner provides the Oxistar® sensor to the patient. This sensor records arterial blood oxygen saturation (SpO2), heart rate and movement. It was developed and manufactured in Brazil.
The patient’s app
The Biologix app is available for both Android and iOS. It is required for patients to fill out their medical forms, to start and conclude the Biologix Sleep Test®. The app is intuitive and easy to use.
The Practitioner’s Portal
The Biologix cloud portal features algorithms with artificial intelligence and an encrypted database. Healthcare practitioners can access their patients’ test results here.
The report
After the patient concludes the Biologix Sleep Test®, a report is generated in a matter of seconds. The information is presented through graphs (polysomnograms) that detail the entire night of sleep of the patient. It is signed by a sleep physician.
Does Your Patient Snore?
The Biologix Snoring Test® allows you to evaluate your patient's snoring without the need for an Oxistar® sensor. Using artificial intelligence, the Test records and assesses the patient's snoring during the night. It thus provides information on both the intensity and the percentage of snoring time throughout the sleep period.
Remember: if you are an accredited center, the Biologix Snoring Test® feature is free of charge. You can issue test authorizations to your patients at no additional cost.
About us
Biologix is a Brazilian health tech company focused on sleep medicine and supported by science. Our mission is to democratize the diagnosis and treatment of sleep disorders by implementing technologies such as the Internet of Things (IoT), artificial intelligence, and cloud computing. We develop, produce, and patent all our products, including sensors, algorithms, and platforms.
A test supported by the health community
more than 5.000 centros credenciados offer the Biologix Sleep Test® to their patients.
more than 300 mil Exames do Sono Biologix® realizados, cerca de 13 mil por mês
Our commitment to science
Did you know that Biologix has a department entirely dedicated to scientific research? In addition to conducting internal scientific research, we cultivate strong partnerships with educational institutions, the medical community, and renowned researchers.
Publications
The corporate culture of Biologix advocates for innovation and scientific rigor regarding the development of all solutions. Our methodology for diagnosing sleep apnea and the additional algorithms developed to enhance the clinical report use modern artificial intelligence tools. Furthermore, scientific publications in reputable journals validate them within the medical community. Thus, we are committed to providing the best-proven benefits to our clients.
Validation Of An Overnight Wireless High-Resolution Oximeter Plus Cloud-Based Algorithm For The Diagnosis Of Obstructive Sleep Apnea
A comparative study of 304 patients undergoing a full type I polysomnography while simultaneously carrying out the Biologix Sleep Test® on the same night. The results were impressive and demonstrated around 90% sensitivity, specificity, and accuracy for the simplified test along with the oximeter and the Biologix solution.
Clinics 11/2020
Validation Of An Overnight Wireless High-Resolution Oximeter For The Diagnosis Of Obstructive Sleep Apnea At Home
A comparative study of 478 patients undergoing a full type III portable polysomnography while simultaneously carrying out the Biologix Sleep Test® on the same night. The results were impressive and demonstrated around 94%
sensitivity, specificity, and accuracy for the simplified test along with the oximeter and the Biologix solution.
Scientific Reports – Nature 09/2022
Pesquisar nesta área